Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genhong Cheng

Showing results (31-40 of 247) with videos related to

Pageof 25
Sort By:
Journal of Leukocyte Biology|February 23, 2007
Innate immune system regulation of nuclear hormone receptors in metabolic diseasesEdward Kai-Hua Chow, Bahram Razani, Genhong Cheng
Journal of Endotoxin Research|September 7, 2006
The interferon response to bacterial and viral infectionsEric M Pietras, Supriya K Saha, Genhong Cheng
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2008
Control of canonical NF-kappaB activation through the NIK-IKK complex pathwayBrian Zarnegar, Soh Yamazaki, Jeannie Q He, et al.
Scientific Reports|November 30, 2019
Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumoniaMingyue Yang, Fanzheng Meng, Man Gao, et al.
Plos One|March 3, 2011
PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathwayGang Wang, Gang Chen, Dahai Zheng, et al.
Cancer Research|January 25, 2005
Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosisAli R Jazirehi, Sara Huerta-Yepez, Genhong Cheng, et al.
Molecular Immunology|December 16, 2010
MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signalingJihuan Fu, Yanbao Xiong, Youli Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 productionElmer Y Chang, Beichu Guo, Sean E Doyle, et al.
Cellular & Molecular Immunology|June 22, 2022
SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1Shilei Zhang, Jingfeng Wang, Lulan Wang, et al.
ACS Nano|February 12, 2009
Copolymeric nanofilm platform for controlled and localized therapeutic deliveryEdward Kai-Hua Chow, Erik Pierstorff, Genhong Cheng, et al.
Pageof 25

Showing results (31-40 of 247) with videos related to

Sort By:
Pageof 25
Journal of Leukocyte Biology|February 23, 2007
Innate immune system regulation of nuclear hormone receptors in metabolic diseasesEdward Kai-Hua Chow, Bahram Razani, Genhong Cheng
Journal of Endotoxin Research|September 7, 2006
The interferon response to bacterial and viral infectionsEric M Pietras, Supriya K Saha, Genhong Cheng
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2008
Control of canonical NF-kappaB activation through the NIK-IKK complex pathwayBrian Zarnegar, Soh Yamazaki, Jeannie Q He, et al.
Scientific Reports|November 30, 2019
Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumoniaMingyue Yang, Fanzheng Meng, Man Gao, et al.
Plos One|March 3, 2011
PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathwayGang Wang, Gang Chen, Dahai Zheng, et al.
Cancer Research|January 25, 2005
Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosisAli R Jazirehi, Sara Huerta-Yepez, Genhong Cheng, et al.
Molecular Immunology|December 16, 2010
MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signalingJihuan Fu, Yanbao Xiong, Youli Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 productionElmer Y Chang, Beichu Guo, Sean E Doyle, et al.
Cellular & Molecular Immunology|June 22, 2022
SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1Shilei Zhang, Jingfeng Wang, Lulan Wang, et al.
ACS Nano|February 12, 2009
Copolymeric nanofilm platform for controlled and localized therapeutic deliveryEdward Kai-Hua Chow, Erik Pierstorff, Genhong Cheng, et al.
Pageof 25